GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Plus Therapeutics Inc (STU:XMP0) » Definitions » Change In Other Working Capital

Plus Therapeutics (STU:XMP0) Change In Other Working Capital : €1.00 Mil (TTM As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Plus Therapeutics Change In Other Working Capital?

Plus Therapeutics's Change In Other Working Capital for the quarter that ended in Mar. 2025 was €0.38 Mil. It means Plus Therapeutics's Other Working Capital increased by €0.38 Mil from Dec. 2024 to Mar. 2025 .

Plus Therapeutics's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was €-0.87 Mil. It means Plus Therapeutics's Other Working Capital declined by €0.87 Mil from Dec. 2023 to Dec. 2024 .

Plus Therapeutics Change In Other Working Capital Historical Data

The historical data trend for Plus Therapeutics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Plus Therapeutics Change In Other Working Capital Chart

Plus Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 -0.44 -0.81 2.35 -0.87

Plus Therapeutics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.43 2.05 -1.01 -0.41 0.38

Plus Therapeutics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plus Therapeutics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Plus Therapeutics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Plus Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Plus Therapeutics Inc (STU:XMP0) » Definitions » Change In Other Working Capital
Comparable Companies
EYEN CMND CELZ ENSC PTNT ATNF DRMA AZTR ADIL XBIO VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
PSTV:USA
Address
2710 Reed Road, Suite 160, Houston, TX, USA, 77051
Website
https://www.plustherapeutics.com
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Plus Therapeutics Headlines

No Headlines